For GBM, we confirmed our previous results (Shteinfer‐Kuzmine et al., 2017), with R‐Tf‐D‐LP4 peptide treatment eliminating the expression of S100b and Nestin (Fig. 9E). The gene discussed is NES; the disease is glioblastoma.